Mark M. Painter

4.3k citations
13 papers · 281 · h-index 7

Impact in

  • Virology top 5%
    • HIV Research and Treatment
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses

Papers in

    • HIV/AIDS drug development and treatment 4
    • HIV/AIDS Research and Interventions 3
    • SARS-CoV-2 and COVID-19 Research 2
    • COVID-19 Clinical Research Studies 2
    • HIV Research and Treatment 7

Mark M. Painter

9 papers receiving 277 citations

Peers

Mark M. Painter
Comparison fields: 5 of 47
  • Virology 98
  • Immunology 155
  • Infectious Diseases 91
  • Oncology 74
  • Hematology 15
Replace Mary-Aude Rochat with:
Mary-Aude Rochat Switzerland
Aljawharah Alrubayyi United Kingdom
Marie‐Ève Blais United Kingdom
Angéline Rouers France
David S. Quinn United States
Mahmoud Mohammad Yaseen Jordan
Nadia Kettaf Canada
Edurne García-Vidal Spain
Yvonne B. Sullivan United States
Thomas N. Denny United States
Mark M. Painter relative to Mary-Aude Rochat Switzerland Mary-Aude Rochat's profile →
Citations per field
00.5×3.9×
Mary-Aude Rochat · 1×
Citations per year

Countries citing papers authored by Mark M. Painter

Since Specialization
Citations

This map shows the geographic impact of Mark M. Painter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark M. Painter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark M. Painter more than expected).

Fields of papers citing papers by Mark M. Painter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark M. Painter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark M. Painter. The network helps show where Mark M. Painter may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark M. Painter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark M. Painter Line = papers co-authored together Mark M. Painter links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 2022119
2 201844
3 201833
4 202433
5 202024
6 201717
7 20068
8 20242
9 20241
10 20220
11 20250
12 20220
13 20020

About Mark M. Painter

Mark M. Painter is a scholar working on Infectious Diseases, Virology, Immunology, Public Health, Environmental and Occupational Health and Epidemiology, having authored 13 papers that have together received 281 indexed citations. Recurring topics across this work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (4 papers), Immune Cell Function and Interaction (4 papers), HIV/AIDS Research and Interventions (3 papers), Health Promotion and Cardiovascular Prevention (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Influenza Virus Research Studies (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Virology (98 citations), Immunology (155 citations), Infectious Diseases (91 citations), Oncology (74 citations) and Hematology (15 citations). Mark M. Painter has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Kathleen L. Collins, Valeri H. Terry, E. John Wherry, Shin Foong Ngiow, Mohamed S. Abdel-Hakeem, Alexander C. Huang, Tara C. Mitchell, Omar Khan, Jennifer E. Wu and Xiaowei Xu. Their work appears in journals such as Journal of Virology, Nature Communications, Cell Reports, Immunity and Nature Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact